Marta Lancione1,2, Matteo Cencini1,2, Elena Scaffei1,3, Emilio Cipriano1,4, Guido Buonincontri1, Chiara Ticci1, Rosa Pasquariello1, Roberta Battini1,5, Raffaello Canapicchi1, Laura Biagi1,2, Michela Tosetti1,2, and Italian DEvelopmental Age Health Network (IDEA)6
1IRCCS Stella Maris, Pisa, Italy, 2Imago7 Research Foundation, Pisa, Italy, 3Department of Neuroscience, Psychology, Drug Research and Child Health, Neurofarba, University of Florence, Florence, Italy, 4Department of Physics, University of Pisa, Pisa, Italy, 5Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 6Italian DEvelopmental Age Health Network (RETE IDEA Ministry of Health), Rome, Italy
Synopsis
New biomarkers
for myelination could improve the understanding of neurodevelopmental diseases
and their diagnosis and treatment. We quantified Myelin Water Fraction (MWF)
using MRF in a cohort of children with leukoencephalopathies and age-matched
controls and we compared it to DTI-based FA. We obtained normative curves of white
matter development with both techniques. MWF discriminated between controls and
patients with higher sensitivity than FA, it was more myelin-specific and
independent of the degree of axonal packing. Thanks to short scan time and
simultaneous acquisition of other quantitative maps, MRF-based MWF may
represent a valuable tool to study developmental disorders.
Introduction
Neurodevelopmental
disorders can hamper white matter (WM) myelination, which represents a crucial
process in normal brain maturation1. The assessment of a biomarker
capable of revealing alterations in myelin content would shed light on
pathological mechanisms and improve clinical diagnosis, treatment and
follow-up. In clinical practice, WM maturation and integrity are commonly
assessed using Diffusion Tensor Imaging (DTI), thanks to the wide-spread
availability of the acquisition protocols and analysis software. However, DTI-based measurements
such as Fractional Anisotropy (FA) suffer from well-acknowledged limitations
in the presence of complex fiber architecture2 and are not
myelin-specific, also reflecting axon diameter and axonal packing3.
In this work, we aimed at quantifying Myelin Water Fraction (MWF) using
multi-component 3D-MR Fingerprinting (MRF)4 which enables
high-resolution multi-parametric mapping in a short scanning time and it is
expected to specifically detect myelin content.
We assessed
age-specific normative MWF in a cohort of healthy children and compared it to
MWF estimation obtained in pediatric patients with WM disorders. Diagnostic
capability of MRF-based MWF estimations was compared to standard DTI-based
evaluation.Methods
We included
19 healthy subjects and 12 children (aged 3months-12years) with several types
of acquired or genetically determined leukoencephalopathies5. The
acquisition protocol performed with a 1.5T MRI system included: DTI (voxel
size=3x3x3mm3, 30 gradient directions, b=1000s/mm2), 3D
spiral projection SSFP-MRF (voxel size=1.1x1.1x1.1mm3;
inversion-prepared variable flip angle scheme with fixed TE/TR=0.5ms/8.5ms) and
a 3D T1-weighted image (voxel size=1x1x1mm3) for anatomical
reference.
MRF-based MWF
maps were obtained by removing cerebrospinal fluid signal6 and
matching tissue-only signal evolutions with a precomputed two-component
dictionary, i.e., Intra/Extra-cellular (IEW) and Myelin Water (MW), based on
Extended Phase Graphs simulation including chemical exchange effects7 (myelin
fraction resolution: 0.01) (Figure 1A).
FA maps were
computed after denoising and correcting DTI data for distortions and head
movement.
Spherical
ROIs (radius=3mm) on the splenium and genu of Corpus Callosum (CC) and to
left/right Corona Radiata (CR) were created on the T1-weighted images (Figure
1B), except for one patient with agenesis of CC. DTI-b0 and MRF-based
T1-weighted synthetic images were skull-stripped and registered to the
skull-stripped anatomical image. Transformation matrices were then applied to
FA and MWF maps, respectively. Average FA and MWF and the corresponding
standard deviations within each ROI were reported as a function of the patient
age. MWF data of control subjects was fitted using a modified Gompertz function8:
$$MWF(age) =\alpha⋅exp(-exp(\beta-\gamma⋅age)+\delta⋅age)$$
where α represents a transition
period between the two different growth rates γ and δ, and β represents a delay time before the development starts. FA data was
fitted using a monoexponential curve9.Results
Using the proposed three-component
model, MRF-based MWF maps were successfully obtained in addition to T1/T2/PD
maps. Maps of a
representative subject are shown in Figure 2, while Figure 3 displays MWF and
FA maps of a patient and an age-matched control subject. The normative WM
maturation curves are shown in Figure 4. The curve obtained via MWF showed a
steeper increase during the first 2 years with respect to FA and reaches a
plateau around the fourth year for the genu and splenium of CC, while MWF in CR
continues growing, though at a slower rate. MWF reaches similar values (∼0.35) in CC and CR while FA in CR is much lower than in CC (∼0.40 and ∼0.75,
respectively). Patients with WM disorders show MWF values lying below the
normative curve, outside the boundaries of the 95% confidence interval of the
fitted curve for both CC and CR in 73% and 82% of cases, respectively. Instead,
FA values are comparable to those of control subjects for most patients,
showing lower values in 27% and 45% of cases for genu and splenium of CC,
respectively, and 33% for CR.Discussion
We derived normative
curves of WM maturation using both MWF and FA. MWF shows similar values in WM
tracts with different degrees of axonal packing, suggesting that it is
independent of the macro-organization of the specific fiber bundle and more
myelin-specific than FA. Patients with impaired myelination processes are
better distinguished from healthy children by MWF measurement rather than FA,
showing strongly reduced MWF with respect to age-matched controls. Hence, MWF
shows higher specificity and sensitivity to myelination variation. Future work
will focus on increasing the sample size and on studying specific WM lesions to
explore the potential of MWF and FA in disentangling different contributions to
WM disruption.Conclusion
MRF-based MWF
provides a measure of WM maturation capable of revealing age-related
differences and of discriminating between control subjects and patients with WM
impairment. As it allows the simultaneous acquisition of high-resolution
quantitative maps such as T1, T2 and PD, other than MWF, in a scanning time
comparable to that of DTI, it may represent a valuable tool in the study of
developmental disorders in pediatric populations.Acknowledgements
This study was supported by the
Italian Ministry of Health, under the project BIaNCA, Pediatric Network IDEA. This
work has been partially supported also by the grant “RC 2018-2020” and “5 per
mille” to IRCCS Fondazione Stella Maris, funded by the Italian Ministry of Health.References
1. Lebel
C. and Deoni S. The development of brain white matter
microstructure. Neuroimage, 2018, 182: 207-218.
2. Jeurissen B., et al.
Investigating the prevalence of complex fiber configurations in white
matter tissue with diffusion magnetic resonance imaging. Human brain mapping, 2013, 34.11: 2747-2766.
3. Beaulieu C. The biological basis
of diffusion anisotropy. In: Diffusion MRI. Academic Press,
2014. p. 155-183.
4. Ma D., et al. Magnetic resonance
fingerprinting. Nature, 2013, 495.7440: 187-192.
5. Van der Knaap MS., et al.
Diagnosis, prognosis, and treatment of leukodystrophies. The Lancet Neurology, 2019, 18.10: 962-972.
6. Deshmane A., et al. Accurate
Synthetic FLAIR Images Using Partial Volume Corrected MR Fingerprinting.
Proceedings of the 24th Annual Meeting of ISMRM 2016.
https://archive.ismrm.org/2016/1909.html
7. Malik, S., et al. Extended phase
graph formalism for systems with magnetization transfer and
exchange. Magnetic resonance in medicine, 2018, 80.2: 767-779.
8. Dean DC., et al. Modeling
healthy male white matter and myelin development: 3 through 60 months of
age. Neuroimage,
2014, 84: 742-752.
9. Paydar
A., et al. Diffusional kurtosis imaging of the developing brain. American Journal of Neuroradiology,
2014, 35.4: 808-814.